Sulfated Derivatives of Escherichia coli K5 Capsular Polysaccharide Are Potent Inhibitors of Human Cytomegalovirus

To date, there are few drugs licensed for the treatment of human cytomegalovirus (HCMV) infections, most of which target the viral DNA polymerase and suffer from many drawbacks. Thus, there is still a strong need for new anti-HCMV compounds with novel mechanisms of action. In this study, we investig...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mercorelli, Beatrice, Oreste, Pasqua, Sinigalia, Elisa, Muratore, Giulia, Lembo, David, Palù, Giorgio, Loregian, Arianna
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology (ASM) 2010
Materias:
Antiviral Agents
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2976136/
https://ncbi.nlm.nih.gov/pubmed/20713657
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00721-10
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares